Aion Therapeutic Inc. (ANTCF)
OTCMKTS
· Delayed Price · Currency is USD
0.0055
0.00 (0.00%)
At close: Apr 23, 2025
Aion Therapeutic Revenue
Aion Therapeutic had revenue of 544.99K CAD in the quarter ending January 31, 2025, with 145.44% growth. This brings the company's revenue in the last twelve months to 1.47M, up 563.34% year-over-year. In the fiscal year ending April 30, 2024, Aion Therapeutic had annual revenue of 367.48K.
Revenue (ttm)
1.47M CAD
Revenue Growth
+563.34%
P/S Ratio
3.53
Revenue / Employee
294.58K CAD
Employees
5
Market Cap
3.59M USD
Revenue Chart
* This company reports financials in CAD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Silence Therapeutics | 43.26M |
Aion Therapeutic News
- 5 months ago - Aion Therapeutic Provides Update on Non-Brokered Private Placement Offering of Units - Newsfile Corp
- 5 months ago - Aion Therapeutic Announces Revocation of MCTO - Newsfile Corp
- 6 months ago - Aion Therapeutic Provides Bi-Weekly MCTO Status Update - Newsfile Corp
- 6 months ago - Aion Therapeutic Hires CRO for Toppen Health; Announces Director Resignation - Newsfile Corp
- 6 months ago - Aion Therapeutic Announces Non- Brokered Private Placement Offering of Units - Newsfile Corp
- 7 months ago - Aion Therapeutic Announces Closing of First Tranche of Non-Brokered Private Placement Offering of Units - Newsfile Corp
- 8 months ago - Aion Therapeutic Announces Grant of Management Cease Trade Order - Newsfile Corp
- 8 months ago - Aion Therapeutic Announces Non-Brokered Private Placement Offering of Units - Newsfile Corp